Should AI be used to resurrect extinct species like the Neanderthal? | Mohammad Hosseini
Two major automakers are joining forces to survive
Incoming White House deputy chief of policy Stephen Miller explains President-elect Donald Trump’s second term agenda on ‘Hannity.’ FIRST ON FOX : A conservative legal group is putting "sanctuary" jurisdictions across the U.S. on notice ahead of an expected mass deportation by the incoming Trump administration . America First Legal says it has notified nearly 250 officials in jurisdictions which limit or forbid local law enforcement cooperation with Immigration and Customs Enforcement (ICE) that there could be legal consequences for interfering with the feds or for concealing illegal immigrants. President-elect Trump has promised to launch a "historic" deportation campaign when in office, and his transition team has already been making concrete steps toward that goal. America First Legal’s president is Stephen Miller, who will serve as deputy chief of staff for policy in the Trump White House. TRUMP BORDER CZAR BLASTS NY GOVERNOR FOR TOUTING SUBWAY SAFETY HOURS AFTER HORRIFIC MURDER President-elect Donald Trump speaks at AmericaFest, Sunday, Dec. 22, 2024, in Phoenix. (AP Photo/Rick Scuteri) But a number of Democratic officials in states including in Arizona, Colorado, California and Massachusetts have said they will not cooperate with the operation. Trump’s border czar, Tom Homan, has hinted there could be legal consequences for those who get in the way of the operation. Proponents of sanctuary policies argue that local jurisdictions cannot be compelled to assist the government, and that barring ICE cooperation encourages otherwise law-abiding illegal immigrants to work with police and report crimes, making the area safer. Opponents say that policies result in the release of otherwise-deportable criminals back onto the streets. AFL’s notice letter to the 249 officials says that the federal government has ultimate authority over immigration, and points to clauses in federal law that prohibit state and local governments from restricting communications with DHS about immigration status, and that make concealing, harboring or shielding an illegal immigrant a federal crime. The group argues that sanctuary policies can therefore lead to criminal liability, and that victims of illegal immigrant crime may be able to sue for damages. "We have identified your jurisdiction as a sanctuary jurisdiction that is violating federal law. Such lawlessness subjects you and your subordinates to significant risk of criminal and civil liability. Accordingly, we are sending this letter to put you on notice of this risk and insist that you comply with our nation’s laws," the letter says. The group is also launching a new website that gives users a map of "sanctuary strongholds," identifying jurisdictions with sanctuary policies and giving contact information for elected officials. TRUMP'S INCOMING BORDER CZAR HAILS MEETING WITH MAYOR ERIC ADAMS: ‘NYC IS ABOUT TO GET A LOT SAFER’ REVERE, MA. - SEPTEMBER 25: ICE agents make arrests on September 25, 2019 in Revere, Massachusetts. (Staff Photo By Matt Stone/MediaNews Group/Boston Herald) The group also announced that it has also filed a petition with the DOJ’s Office of Violence Against Women to seek data on citizenship status and nationality information against those charged with a slew of crimes against women and children, including domestic violence, murder and child maltreatment. In addition, it is filing requests to officials, including mayors and governors, across the U.S. for information on organizations it believes are undermining federal immigration enforcement. In a statement, America First Legal's Senior Vice President Reed D. Rubenstein pointed to the recent arrest of an illegal immigrant in New York City in connection with the death of a woman who was set on fire and burned to death as "another reminder that open borders and sanctuary jurisdictions are sheer insanity." "The left-wing politicians who create and run them, and those who support them, put our citizens at risk, undermine our Constitution, and dangerously erode the rule of law. America First Legal will continue working tirelessly to protect our immigration laws and support the brave men and women who enforce them. Today’s actions are but a first step in our fight against sanctuary lawlessness," Rubenstein said. The new announcements shine a spotlight on what could be a fierce fight between the Trump administration, and its allies, and Democrats and left-wing activists over the deportation push and the extent to which it can be resisted at state and local level. CLICK HERE FOR MORE COVERAGE OF THE BORDER SECURITY CRISIS Some have doubled down on their opposition, with the Boston City Council recently voting to limit ICE cooperation and to ban police from keeping migrants in custody for possible deportation unless there is a criminal warrant. The resolution adopted by the council states that "proposals for mass deportations represent a direct attack on Boston’s immigrant families, and threaten to tear communities apart." Some Democratic officials, however, have indicated their willingness to work with the incoming administration. Homan met with New York City Mayor Eric Adams last week to discuss areas of potential cooperation, including the deportation of violent illegal immigrant criminals. Illinois Gov. J.B. Pritzker also said he wanted to see "violent criminals who are undocumented and convicted of violent crime" deported, and said he would welcome a meeting with Homan. CLICK HERE TO GET THE FOX NEWS APP Fox News reported this month on new data provided to Congress that showed there are 1.4 million noncitizens who have deportation orders but are not currently in Immigration and Customs Enforcement (ICE) detention. Adam Shaw is a politics reporter for Fox News Digital, primarily covering immigration and border security. He can be reached at adam.shaw2@fox.com or on Twitter .Lightweight portion of the Bucs’ schedule begins with an easy win vs. Giants
France gets fourth government in a year amid potential tussle over new budgetSchieffelin has 18 points, 13 rebounds and 8 assists as Clemson hands Penn State first loss 75-67
(Reuters) - Databricks, the data analytics firm which has long been the subject of IPO speculation, is close to raising $8 billion via deals that would value it at $55 billion, according to a source familiar with the matter. Most of the new funding would be in the form of a secondary share sale, where early investors and employees are allowed to cash out some of their stock holdings, the source said. Such deals can boost employee morale, since stock-based payouts typically comprise a big chunk of the compensation at startups, while allowing the company to sidestep an initial public offering. Several high-flying startups are seeking to stay private for longer to avoid the regulatory burden and market volatility associated with being public. The flexibility via secondary sales also gives them more time to strengthen their finances. Major venture capital investors Thrive Capital and DST Global are participating in the fundraising by Databricks, two sources said. Databricks did not immediately respond to a Reuters request for comment. The potential fundraising was earlier reported by CNBC. The company had notched up a valuation of $43 billion after a $500 million funding round last year. (Reporting by Krystal Hu in New York and Niket Nishant in Bengaluru; Editing by Shilpi Majumdar)Jennison Associates LLC bought a new stake in shares of BridgeBio Pharma, Inc. ( NASDAQ:BBIO – Free Report ) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 30,119 shares of the company’s stock, valued at approximately $767,000. Other large investors have also bought and sold shares of the company. Bfsg LLC lifted its holdings in BridgeBio Pharma by 175.6% in the 2nd quarter. Bfsg LLC now owns 1,240 shares of the company’s stock valued at $31,000 after acquiring an additional 790 shares during the last quarter. Headlands Technologies LLC bought a new stake in shares of BridgeBio Pharma in the 2nd quarter worth approximately $48,000. Values First Advisors Inc. bought a new stake in shares of BridgeBio Pharma in the 3rd quarter worth approximately $57,000. CWM LLC lifted its stake in BridgeBio Pharma by 132.9% during the third quarter. CWM LLC now owns 3,442 shares of the company’s stock valued at $88,000 after purchasing an additional 1,964 shares during the last quarter. Finally, Amalgamated Bank boosted its holdings in BridgeBio Pharma by 24.7% during the second quarter. Amalgamated Bank now owns 4,863 shares of the company’s stock worth $123,000 after buying an additional 962 shares in the last quarter. Institutional investors own 99.85% of the company’s stock. BridgeBio Pharma Stock Performance BridgeBio Pharma stock opened at $23.42 on Friday. BridgeBio Pharma, Inc. has a twelve month low of $21.62 and a twelve month high of $44.32. The firm has a market cap of $4.43 billion, a PE ratio of -9.72 and a beta of 1.09. The firm’s 50 day moving average price is $24.96 and its two-hundred day moving average price is $26.25. Analysts Set New Price Targets Get Our Latest Analysis on BridgeBio Pharma Insider Activity In related news, CEO Neil Kumar sold 27,389 shares of the business’s stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $22.41, for a total value of $613,787.49. Following the completion of the sale, the chief executive officer now owns 4,897,443 shares of the company’s stock, valued at approximately $109,751,697.63. The trade was a 0.56 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link . Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the transaction, the insider now directly owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. The trade was a 18.67 % decrease in their position. The disclosure for this sale can be found here . Insiders have sold a total of 5,831,545 shares of company stock worth $150,056,923 in the last ninety days. Corporate insiders own 24.66% of the company’s stock. About BridgeBio Pharma ( Free Report ) BridgeBio Pharma, Inc, a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. Its products in development programs include AG10, a next-generation oral small molecule near-complete TTR stabilizer that is in Phase 3 clinical trial for the treatment of TTR amyloidosis, or transthyretin amyloid cardiomyopathy (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 double-blinded, placebo-controlled pivotal study for the treatment option for children with achondroplasia; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 1/2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. Featured Stories Receive News & Ratings for BridgeBio Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BridgeBio Pharma and related companies with MarketBeat.com's FREE daily email newsletter .
Israel and Lebanon's Hezbollah agree to a ceasefire after nearly 14 months of fighting